COVID-19 vaccine: Serum Institute seeks indemnity against liabilities

COVID-19 vaccine: Serum Institute seeks indemnity against liabilities
This development comes a day after reports suggested that the Centre is leaning towards granting indemnity to foreign vaccine makers including Pfizer and Moderna
BusinessToday.In | June 3, 2021 | Updated 09:26 IST
Serum Institute seeks indemnity
Serum Institute of India whose, Covishield vaccine is currently being administered to citizens under India's vaccination programme, has sought indemnity against liabilities. This development comes a day after reports suggested that the Centre is leaning towards granting indemnity to foreign vaccine makers including Pfizer and Moderna.
According to a report by ANI, the Adar Poonawalla-helmed vaccine giant is seeking indemnity from the Centre. Sources told the news agency that if foreign vaccine makers are getting indemnity, then all Indian vaccine makers should get indemnity against liabilities.

Related Keywords

India ,Kasauli ,Himachal Pradesh , ,Pfizer ,Central Drugs Laboratory ,Serum Institute Of India ,Serum Institute ,Adar Poonawalla Helmed ,Indemnity ,Indemnity For Vaccine Makers ,Vaccine Makers Indemnity ,Serum Institute Indemnity ,Serum Institute Seeks Indemnity ,What Is Indemnity ,Indemnity For Serum Institute ,Adar Poonawalla ,இந்தியா ,கச Ul லி ,இமாச்சல் பிரதேஷ் ,ஃபைசர் ,மைய மருந்துகள் ஆய்வகம் ,சீரம் நிறுவனம் ஆஃப் இந்தியா ,சீரம் நிறுவனம் ,இழப்பெதிர்காப்புப் ,இழப்பெதிர்காப்புப் க்கு தடுப்பூசி தயாரிப்பாளர்கள் ,அடார் பூனாவல்ல ,